“I think other countries will now be looking at India and saying, ‘Well, hold on a minute — India stuck to its guns,’ ” said Tahir Amin, a director of the Initiative for Medicines, Access and Knowlhttp://www.nytimes.com/2013/04/02/business/global/top-court-in-india-rejects-novartis-drug-patent.html?pagewanted=all&_r=0edge, a group based in New York that works on patent cases to foster access to drugs.
Learn more about how you can help build a more equitable system for all Notice: JavaScript is required for this content.